Opus Genetics, Inc.
For the period ended Dec 31, 2025. Filed Mar 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 12, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. PROPERTIES
| ITEM 2. | PROPERTIES |
|---|
As of December 31, 2025, pursuant to our lease agreements, we lease office and laboratory space in Durham, North Carolina:
| Property Location | Approximate Square Footage | Use | Lease Expiration |
|---|---|---|---|
| 8 Davis Drive, Suite 220 Durham, NC 27713 | 232 | Laboratory and Office | Month-to-month |
| 701 West Main Street, Suite 200 Durham, NC 27707 | 113 | Laboratory and Office | Month-to-month |
We may extend our current space or require additional space and facilities as our business expands, and we believe that suitable additional and alternative spaces will be available in the future on commercially reasonable terms.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.